Peg-IFNα-2a

DRUG2 trials

Sponsors

Beijing 302 Hospital, Arbutus Biopharma Corporation

Conditions

Chronic Hepatitis BChronic Hepatitis b

Phase 2

Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection

CompletedNCT04980482

Arbutus Biopharma CorporationChronic Hepatitis b

Start: 2021-10-29End: 2025-05-21Updated: 2025-10-22

Phase 4

Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B

Beijing 302 HospitalChronic Hepatitis B

Start: 2011-07-31End: 2016-07-31Target: 105Updated: 2015-08-17